Medicare beneficiaries planning their 2027 budgets now have a concrete number to work with. The 2026 Medicare Trustees Report, released June 9, 2026, projects the standard Part B monthly premium at $209.50 for 2027. That figure is lower than what the prior year’s Trustees Report had estimated for the same period, signaling a downward revision driven by shifting cost assumptions inside the program.
Why the $209.50 projection dropped from last year’s estimate
The revision matters because millions of enrollees and the state Medicaid programs that cover their premiums set spending plans around these out-year numbers. A lower projection eases near-term budget pressure, but it also raises a question: is the decline a one-time adjustment, or the start of a trend?
The 2026 Trustees report lists $209.50 in Table V.E2 as the intermediate estimate for the standard Part B monthly premium in 2027. The intermediate scenario reflects current-law assumptions and sits between the Trustees’ low-cost and high-cost alternatives. By contrast, the corresponding table in the 2025 report had placed the 2027 premium at a higher level, based on older data and earlier expectations about how fast Part B spending would grow.
That year-over-year drop did not happen by accident. Each spring, CMS releases a rate announcement for Medicare Advantage and Part D that embeds updated projections of per-capita spending in Original Medicare. For calendar year 2027, those underlying assumptions pointed to slower growth in costs per enrollee than actuaries had built into the 2025 projections. When the Trustees incorporated those fresher figures, the model produced a lower premium path for 2027 than previously anticipated.
If Medicare Advantage and Original Medicare per-capita cost growth continue to moderate at the pace reflected in those assumptions, future Trustees Reports could revise the 2027 premium even further downward before CMS sets the final rate. Premiums are formally determined each fall under the Social Security Act, meaning the $209.50 figure is a planning estimate, not a locked-in price. CMS typically publishes a fact sheet each autumn confirming the actual premium and deductible amounts for the coming calendar year, as it did for the 2025 benefit year, and it will follow the same process for 2027.
How the Trustees calculated the 2027 Part B number
The Boards of Trustees report annually on the financial status of the Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds. Their 2026 edition, formally titled the “2026 Annual Report of the Boards of Trustees of the Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds,” was prepared by the CMS Office of the Actuary and lays out detailed projections for spending, revenues, and enrollee cost sharing.
Within that document, Table V.E2 breaks out projected Supplementary Medical Insurance (SMI) Part B cost-sharing and premium amounts year by year. The $209.50 intermediate estimate for 2027 sits in that table alongside projections for surrounding years, offering a trajectory rather than a single data point. For example, the table shows how the standard premium is expected to evolve from 2026 through the end of the decade under intermediate assumptions, allowing analysts to compare the 2027 figure with both prior and subsequent years.
The downward move between the 2025 and 2026 reports reflects updated inputs, including macroeconomic assumptions such as wage and price growth, utilization trends in physician and outpatient services, and any legislative or regulatory changes that affect Part B spending. The Trustees also incorporate recent experience data, such as actual spending in the most recent year and observed shifts in enrollment between Original Medicare and Medicare Advantage.
No public statement from CMS actuaries has isolated a single driver behind the revision. Instead, the available evidence points to a combination of softer per-capita cost growth across Original Medicare and technical refinements to the projection models. Those changes are consistent with the spending assumptions CMS used when setting 2027 Medicare Advantage benchmark rates, which feed back into the overall Part B financing picture.
Open questions before the final 2027 premium is set
Despite the greater clarity offered by the $209.50 projection, several key uncertainties remain before CMS finalizes the 2027 Part B premium this fall. First, actual spending in 2026 could diverge from the assumptions in the Trustees Report. If utilization or prices run higher than expected, the premium may need to be adjusted upward to keep Part B finances in balance; if they come in lower, the final premium could be slightly below the current estimate.
Second, policy changes enacted after the Trustees’ assumptions were locked in could still affect the final number. Congress and CMS retain the ability to modify payment rules, introduce new benefits, or change sequestration and other budget mechanisms that influence Part B outlays. Any such actions would have to be incorporated into the fall premium-setting process, even if they are not fully reflected in the June report.
Third, broader economic conditions will shape beneficiary impacts. The standard Part B premium is typically deducted from Social Security checks, and the “hold harmless” provision limits premium increases for most beneficiaries when Social Security cost-of-living adjustments are small. While the 2027 projection currently points to a manageable increase from 2026, the real burden on beneficiaries will depend on how their income growth compares with the final premium level.
For now, the Trustees’ $209.50 estimate offers beneficiaries, state Medicaid programs, and health plans a more favorable starting point than last year’s projection did. It signals that, based on current information, Medicare’s actuaries expect somewhat slower growth in Part B costs than previously feared. The final figure will not be known until CMS completes its fall rate-setting process, but the latest report narrows the range of plausible outcomes and gives stakeholders a clearer basis for planning 2027 budgets.